DANBURY, Conn. -- (Business Wire)
IMS Health (NYSE:IMS) has been named a leader in IDC Health Insights’
assessment of social media and analytics software and services offerings
available to the life sciences industry. The report, IDC MarketScape:
Worldwide Life Science Social Media Analytics 2014 Vendor Assessment
(doc # HI252646, December 2014), names IMS Health as a leader
for Nexxus™ Social, its best-in-class SaaS solution that monitors
and integrates information from tens of millions of social media sources
worldwide — providing structure and insights that can be used by life
sciences companies to inform key regulatory compliance and commercial
decision-making processes.
The IDC MarketScape report points out that Nexxus Social supports
52 languages and includes “some of the most life science–specific
functionality available in social media analytics software today by any
vendor, and is considered by its customers to be very user friendly and
easy to use.” The report also cites IMS Health’s industry-specific
expertise, strong customer references and proven expertise in delivering
measurable value to clients. The findings were based on a six-month
evaluation of social media analytics software and service offerings.
“Life science companies view social media analytics as an effective tool
for investigating competitive pricing and promotions, evaluating
therapeutic category of consumer trends and related products, and
measuring corporate- and brand-specific consumer perceptions,” said Eric
Newmark, program director of IDC Health Insights’ Life Science Business
Systems Strategy service. “While dozens of vendors offer these services,
few have true proven success in delivering it.”
Nexxus Social, part of IMS Health’s NexxusTM Commercial
Application Suite, automates social media monitoring and evaluation of
social media content, helping to transform this new source of
unstructured data into actionable insights. Its algorithms use semantic
— not keyword — search and proprietary ontologies, including patient
language and Natural Language Processing (NLP), to capture patient and
physician perceptions of treatments on social networks. The ability to
quickly and efficiently harness and act on social media insights can be
a significant advantage in developing enhanced patient engagement and
clinical programs to improve health outcomes.
“Scanning the digital landscape, listening to patients and taking
actions based on more timely insights have become critical elements of
commercial strategies for the life sciences industry. We’re pleased to
be recognized as a leader in this space by IDC MarketScape,” said Siva
Nadarajah, general manager, Social Media, IMS Health.
For highlights of the IDC MarketScape report, click here.
More information about Nexxus Social can be found on the IMS
Health website.
About IMS Health
IMS Health is a leading global information and technology services
company providing clients in the healthcare industry with comprehensive
solutions to measure and improve their performance. By applying
sophisticated analytics and proprietary application suites hosted on the
IMS One™ intelligent cloud, the company connects more than 10
petabytes of complex healthcare data on diseases, treatments, costs and
outcomes to help its clients run their operations more efficiently. More
than 10,000 employees drive results for over 5,000 healthcare clients
across 100 countries, drawing on information from 100,000 suppliers and
insights from more than 55 billion healthcare transactions processed
annually. Customers include pharmaceutical, consumer health and medical
device manufacturers and distributors, providers, payers, government
agencies, policymakers, researchers and the financial community.
As a global leader in protecting individual patient privacy, IMS Health
uses anonymous healthcare data to deliver critical, real-world disease
and treatment insights. These insights help biotech and pharmaceutical
companies, medical researchers, government agencies, payers and other
healthcare stakeholders to identify unmet treatment needs and understand
the effectiveness and value of pharmaceutical products in improving
overall health outcomes. Additional information is available at www.imshealth.com.
About IDC MarketScape
IDC MarketScape vendor analysis model is designed to provide an overview
of the competitive fitness of ICT (information and communications
technology) suppliers in a given market. The research methodology
utilizes a rigorous scoring methodology based on both qualitative and
quantitative criteria that results in a single graphical illustration of
each vendor’s position within a given market. IDC MarketScape provides a
clear framework in which the product and service offerings, capabilities
and strategies, and current and future market success factors of IT and
telecommunications vendors can be meaningfully compared. The framework
also provides technology buyers with a 360-degree assessment of the
strengths and weaknesses of current and prospective vendors.
Contacts:
IMS Health
Tor Constantino, +1 484-567-6732
tconstantino@us.imshealth.com
Source: IMS Health
© 2024 Canjex Publishing Ltd. All rights reserved.